WG Biotech ApS

All filings by WG Biotech ApS on record concern Y-mAbs Therapeutics, Inc. In total, 18 filings cover trades dated from 30 December 2019 to 16 September 2025.

On the open market, the record shows 8 purchases worth €2.5M and 8 sales worth €8.7M. The net balance comes to €6.2M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

A typical purchase (the median) is worth €222k. On 8 out of 8 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The record was last updated on 18 September 2025 with a transaction (€33.0M) in Y-mAbs Therapeutics, Inc. The clock since the last published purchase (12 December 2023) now reads 1,047 days. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.